↓ Skip to main content

GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma

Overview of attention for article published in Investigational New Drugs, February 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
35 Mendeley
Title
GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma
Published in
Investigational New Drugs, February 2019
DOI 10.1007/s10637-019-00741-3
Pubmed ID
Authors

Sonia Brun, Firas Bassissi, Cindy Serdjebi, Marie Novello, Jennifer Tracz, François Autelitano, Marie Guillemot, Philippe Fabre, Jérôme Courcambeck, Christelle Ansaldi, Eric Raymond, Philipe Halfon

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 26%
Other 2 6%
Student > Postgraduate 2 6%
Professor > Associate Professor 2 6%
Student > Master 2 6%
Other 4 11%
Unknown 14 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 14%
Agricultural and Biological Sciences 4 11%
Pharmacology, Toxicology and Pharmaceutical Science 4 11%
Medicine and Dentistry 4 11%
Immunology and Microbiology 1 3%
Other 1 3%
Unknown 16 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2021.
All research outputs
#6,526,116
of 23,130,383 outputs
Outputs from Investigational New Drugs
#273
of 1,177 outputs
Outputs of similar age
#125,159
of 352,633 outputs
Outputs of similar age from Investigational New Drugs
#6
of 23 outputs
Altmetric has tracked 23,130,383 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 1,177 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,633 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.